Merck US Versus Merck Germany: Trademark War Heats Up
This article was originally published in The Tan Sheet
Executive Summary
US Merck alleges "false advertising, deceptive trade practices, cybersquatting and breach of contract" in complaint that follows German Merck's decision to rebrand itself in the lead up to new CEO Stefan Oschmann taking the top job in April 2016
You may also be interested in...
Global Pharma Industry Regulators Seek Unified Approach To Remote Inspections
Remote inspections are here to stay, and global regulators are aligning efforts to develop consensus on how these should be conducted.
Canada Boosts Postmarket Device Safety With New Reporting Rules
Device companies operating in Canada are being advised to review their internal procedures in anticipation of new postmarket requirements that come into force this year.
Global Regulators Seek Unified Approach To Remote Inspections
Remote inspections are here to stay, and global regulators are aligning efforts to develop consensus on how these should be conducted.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: